Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Paratek opens phase IIb study of Nuzyra in M. abscessus pulmonary disease

June 17, 2021

VenatoRx Pharmaceuticals synthesizes new carbapenem derivatives

June 17, 2021

Infex Therapeutics discloses new antibacterials

June 17, 2021

Daiichi Sankyo discontinues development of nafamostat inhalation formulation for COVID-19 in Japan

June 16, 2021

Spero initiates new phase I trials of SPR-206 for MDR Gram-negative infections

June 16, 2021

Ashvattha reports phase II interim data on OP-101 to treat hyperinflammation in severe COVID-19

June 16, 2021

Cocrystal's CDI-45205 shows in vitro activity against SARS-CoV-2 and variants

June 15, 2021

Novavax reports COVID-19 vaccine data against SARS-CoV-2 Beta variant

June 14, 2021

U.K.'s MHRA clears initiation of phase II trial of COVID-DROPS

June 14, 2021

Berdazimer sodium shows promising efficacy in preclinical SARS-CoV-2 transmission model

June 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...